FDA approves Zepbound for sleep apnea
The Checkup by Singlecare
JANUARY 2, 2025
Food and Drug Administration (FDA) recently approved Zepbound (tirzepatide) as the first prescription drug for obstructive sleep apnea. Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder, according to the Mayo Clinic. Its likely that insurance will cover Zepbound for sleep apnea.
Let's personalize your content